Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases

J Clin Med. 2022 Feb 7;11(3):872. doi: 10.3390/jcm11030872.

Abstract

Endoscopy is the mainstay of inflammatory bowel disease (IBD) evaluation and the pillar of colorectal cancer surveillance. Endoscopic equipment, both hardware and software, are advancing at an incredible pace. Virtual chromoendoscopy is now widely available, allowing the detection of subtle inflammatory changes, thus reducing the gap between endoscopic and histologic assessment. The progress in the field of artificial intelligence (AI) has been remarkable, and numerous applications are now in an advanced stage of development. Computer-aided diagnosis (CAD) systems are likely to reshape most of the evaluations that are now prerogative of human endoscopists. Furthermore, sophisticated tools such as endocytoscopy and probe-based confocal laser endomicroscopy (pCLE) are enhancing our assessment of inflammation and dysplasia. Finally, pCLE combined with molecular labeling could pave the way to a new paradigm of personalized medicine. This review aims to summarize the main changes that occurred in the field of IBD endoscopy and to explore the most promising novelties.

Keywords: Crohn’s disease; artificial intelligence; capsule endoscopy; confocal laser endomicroscopy; endocytoscopy; endoscopy; inflammatory bowel disease; molecular endoscopy; ulcerative colitis; virtual chromoendoscopy.

Publication types

  • Review